# pathway_0138

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **D** — Secondary metabolite biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR

[Multiple Choices]
A. L-fucose degradation. .
B. LPS O-antigen biosynthesis. .
C. terpenoid biosynthesis.
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for FrzH, annotated to secondary metabolite biosynthesis. The pathway annotation carries an experimental evidence code and cites a paper on FR901483 biosynthesis, supporting choice D; this is database-reported experimental evidence, not an independently verified assessment of the paper.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence alone gives no defensible way to identify which of these specific pathways this protein participates in. Recognizing a general enzyme-like sequence would not distinguish secondary-metabolite biosynthesis from the listed alternatives.


**Missing item-specific fact**

> The protein-specific fact that FrzH functions in FR901483 biosynthesis and is annotated to secondary metabolite biosynthesis is absent from the input.


**Reason**

> Selecting D depends on a protein-specific pathway annotation or equivalent external knowledge; the answer is not meaningfully distinguished by the supplied sequence and choices through general biological reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The reviewer evidence supports D for the matched sequence; none of the other choices is similarly supported.


### Important caveats

- Reviewer-only accession and annotation evidence establishes support for the key but was not available to the evaluated model.
- The annotation cites experimental evidence, but the primary paper was not independently retrieved and validated here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence alone gives no defensible way to identify which of these specific pathways this protein participates in. Recognizing a general enzyme-like sequence would not distinguish secondary-metabolite biosynthesis from the listed alternatives.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific fact that FrzH functions in FR901483 biosynthesis and is annotated to secondary metabolite biosynthesis is absent from the input.",
    "reason": "Selecting D depends on a protein-specific pathway annotation or equivalent external knowledge; the answer is not meaningfully distinguished by the supplied sequence and choices through general biological reasoning."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzH, annotated to secondary metabolite biosynthesis. The pathway annotation carries an experimental evidence code and cites a paper on FR901483 biosynthesis, supporting choice D; this is database-reported experimental evidence, not an independently verified assessment of the paper."
  },
  "important_caveats": [
    "Reviewer-only accession and annotation evidence establishes support for the key but was not available to the evaluated model.",
    "The annotation cites experimental evidence, but the primary paper was not independently retrieved and validated here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D for the matched sequence; none of the other choices is similarly supported."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for FrzH, annotated to secondary metabolite biosynthesis. The pathway annotation carries an experimental evidence code and cites a paper on FR901483 biosynthesis, supporting choice D; this is database-reported experimental evidence, not an independently verified assessment of the paper.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence alone gives no defensible way to identify which of these specific pathways this protein participates in. Recognizing a general enzyme-like sequence would not distinguish secondary-metabolite biosynthesis from the listed alternatives.",
    "missing_item_specific_fact": "The protein-specific fact that FrzH functions in FR901483 biosynthesis and is annotated to secondary metabolite biosynthesis is absent from the input.",
    "reason": "Selecting D depends on a protein-specific pathway annotation or equivalent external knowledge; the answer is not meaningfully distinguished by the supplied sequence and choices through general biological reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The reviewer evidence supports D for the matched sequence; none of the other choices is similarly supported."
  },
  "important_caveats": [
    "Reviewer-only accession and annotation evidence establishes support for the key but was not available to the evaluated model.",
    "The annotation cites experimental evidence, but the primary paper was not independently retrieved and validated here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProtKB entry A0A7T8F1L1 (FRZH_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269) from PubMed:33372776 (Zhang et al., JACS 2021). The protein is Aldolase FrzH, a component of the FR901483 (immunosuppressant) biosynthetic gene cluster in Cladobotryum sp. The sequence matches exactly (125 AA, SHA256 confirmed). The annotation is experimentally grounded, not merely computational.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [C4](#evidence-c4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence reveals a class I aldolase fold (conserved GGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR motif with the catalytic Schiff-base lysine). This eliminates terpenoid biosynthesis (which uses terpene synthases/prenyltransferases) and LPS O-antigen biosynthesis (glycosyltransferases/polymerases). However, both L-fucose degradation (which employs a class I fucose-1-phosphate aldolase) and secondary metabolite biosynthesis (which can employ aldolases) remain plausible for an aldolase sequence. Distinguishing D from A requires knowing this is specifically FrzH from the FR901483 gene cluster.


**Missing item-specific fact**

> The identity of this protein as FrzH, a member of the FR901483 biosynthetic gene cluster in Cladobotryum sp., is a protein-specific annotation (from PubMed:33372776) that cannot be inferred from the 125-residue sequence alone. The sequence does not encode organism information, gene-cluster context, or pathway-specific metabolite identity.


**Reason**

> While the aldolase fold narrows the field from four to two plausible options (A and D), selecting 'secondary metabolite biosynthesis' over 'L-fucose degradation' requires knowing the specific gene-cluster membership of this protein. This is an item-specific database fact, not derivable from general biochemical reasoning about aldolase sequences.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "D"
]
```

> Both L-fucose degradation and secondary metabolite biosynthesis involve class I aldolases. From the sequence alone, one can identify the aldolase fold but cannot determine whether the aldolase acts on fucose-1-phosphate (option A) or on a secondary metabolite intermediate (option D). The organism (fungus, not bacterium) would argue against LPS O-antigen (B), and the aldolase chemistry argues against terpenoid biosynthesis (C), but A vs. D remains ambiguous without protein-specific annotation.


### Important caveats

- The UniProt annotation (ECO:0000269) is experimentally supported, not merely inferred by homology, strengthening the key's validity.
- The protein is only 125 residues; the N-terminal ~25 residues (MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGG) lack obvious catalytic motifs, making the sequence less informative for pathway assignment.
- The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must rely solely on the 125-aa sequence and four pathway names.
- The source snapshot used by the benchmark authors is unknown; the current entry (version 8) and the historical version 6 both carry the same pathway annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence reveals a class I aldolase fold (conserved GGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR motif with the catalytic Schiff-base lysine). This eliminates terpenoid biosynthesis (which uses terpene synthases/prenyltransferases) and LPS O-antigen biosynthesis (glycosyltransferases/polymerases). However, both L-fucose degradation (which employs a class I fucose-1-phosphate aldolase) and secondary metabolite biosynthesis (which can employ aldolases) remain plausible for an aldolase sequence. Distinguishing D from A requires knowing this is specifically FrzH from the FR901483 gene cluster.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identity of this protein as FrzH, a member of the FR901483 biosynthetic gene cluster in Cladobotryum sp., is a protein-specific annotation (from PubMed:33372776) that cannot be inferred from the 125-residue sequence alone. The sequence does not encode organism information, gene-cluster context, or pathway-specific metabolite identity.",
    "reason": "While the aldolase fold narrows the field from four to two plausible options (A and D), selecting 'secondary metabolite biosynthesis' over 'L-fucose degradation' requires knowing the specific gene-cluster membership of this protein. This is an item-specific database fact, not derivable from general biochemical reasoning about aldolase sequences."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProtKB entry A0A7T8F1L1 (FRZH_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269) from PubMed:33372776 (Zhang et al., JACS 2021). The protein is Aldolase FrzH, a component of the FR901483 (immunosuppressant) biosynthetic gene cluster in Cladobotryum sp. The sequence matches exactly (125 AA, SHA256 confirmed). The annotation is experimentally grounded, not merely computational."
  },
  "important_caveats": [
    "The UniProt annotation (ECO:0000269) is experimentally supported, not merely inferred by homology, strengthening the key's validity.",
    "The protein is only 125 residues; the N-terminal ~25 residues (MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGG) lack obvious catalytic motifs, making the sequence less informative for pathway assignment.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must rely solely on the 125-aa sequence and four pathway names.",
    "The source snapshot used by the benchmark authors is unknown; the current entry (version 8) and the historical version 6 both carry the same pathway annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "D"
    ],
    "reason": "Both L-fucose degradation and secondary metabolite biosynthesis involve class I aldolases. From the sequence alone, one can identify the aldolase fold but cannot determine whether the aldolase acts on fucose-1-phosphate (option A) or on a secondary metabolite intermediate (option D). The organism (fungus, not bacterium) would argue against LPS O-antigen (B), and the aldolase chemistry argues against terpenoid biosynthesis (C), but A vs. D remains ambiguous without protein-specific annotation."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProtKB entry A0A7T8F1L1 (FRZH_CLASX) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with experimental evidence (ECO:0000269) from PubMed:33372776 (Zhang et al., JACS 2021). The protein is Aldolase FrzH, a component of the FR901483 (immunosuppressant) biosynthetic gene cluster in Cladobotryum sp. The sequence matches exactly (125 AA, SHA256 confirmed). The annotation is experimentally grounded, not merely computational.",
    "evidence_ids": ["C5", "C6", "H3", "C4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence reveals a class I aldolase fold (conserved GGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR motif with the catalytic Schiff-base lysine). This eliminates terpenoid biosynthesis (which uses terpene synthases/prenyltransferases) and LPS O-antigen biosynthesis (glycosyltransferases/polymerases). However, both L-fucose degradation (which employs a class I fucose-1-phosphate aldolase) and secondary metabolite biosynthesis (which can employ aldolases) remain plausible for an aldolase sequence. Distinguishing D from A requires knowing this is specifically FrzH from the FR901483 gene cluster.",
    "missing_item_specific_fact": "The identity of this protein as FrzH, a member of the FR901483 biosynthetic gene cluster in Cladobotryum sp., is a protein-specific annotation (from PubMed:33372776) that cannot be inferred from the 125-residue sequence alone. The sequence does not encode organism information, gene-cluster context, or pathway-specific metabolite identity.",
    "reason": "While the aldolase fold narrows the field from four to two plausible options (A and D), selecting 'secondary metabolite biosynthesis' over 'L-fucose degradation' requires knowing the specific gene-cluster membership of this protein. This is an item-specific database fact, not derivable from general biochemical reasoning about aldolase sequences."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "D"],
    "reason": "Both L-fucose degradation and secondary metabolite biosynthesis involve class I aldolases. From the sequence alone, one can identify the aldolase fold but cannot determine whether the aldolase acts on fucose-1-phosphate (option A) or on a secondary metabolite intermediate (option D). The organism (fungus, not bacterium) would argue against LPS O-antigen (B), and the aldolase chemistry argues against terpenoid biosynthesis (C), but A vs. D remains ambiguous without protein-specific annotation."
  },
  "important_caveats": [
    "The UniProt annotation (ECO:0000269) is experimentally supported, not merely inferred by homology, strengthening the key's validity.",
    "The protein is only 125 residues; the N-terminal ~25 residues (MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGG) lack obvious catalytic motifs, making the sequence less informative for pathway assignment.",
    "The reviewer-only evidence confirms the key but was not available to the evaluated model; the model must rely solely on the 125-aa sequence and four pathway names.",
    "The source snapshot used by the benchmark authors is unknown; the current entry (version 8) and the historical version 6 both carry the same pathway annotation."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A7T8F1L1` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 6. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:45.781236+00:00.  

```json
"A0A7T8F1L1"
```

Source SHA-256: `65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:45.781236+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"FR901483 biosynthesis clusters protein H"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"5.5.1.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"33372776","source":"PubMed"}],"value":"Aldolase FrzH"}}}
```

Source SHA-256: `65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:45.781236+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"value":"Secondary metabolite biosynthesis"}]}
```

Source SHA-256: `65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:45.781236+00:00.  

```json
{"citation":{"authors":["Zhang Z.","Tamura Y.","Tang M.","Qiao T.","Sato M.","Otsu Y.","Sasamura S.","Taniguchi M.","Watanabe K.","Tang Y."],"citationCrossReferences":[{"database":"PubMed","id":"33372776"},{"database":"DOI","id":"10.1021/jacs.0c12352"}],"citationType":"journal article","firstPage":"132","id":"33372776","journal":"J. Am. Chem. Soc.","lastPage":"136","publicationDate":"2021","title":"Biosynthesis of the Immunosuppressant (-)-FR901483.","volume":"143"},"referenceComments":[{"type":"STRAIN","value":"11231"}],"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC DNA]","FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)  
**Locator:** `lines 14-22`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 6 / 1.  
**Retrieved:** 2026-11-02T04:25:48.823356+00:00.  

```text
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   STRAIN=11231;
RX   PubMed=33372776; DOI=10.1021/jacs.0c12352;
RA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,
RA   Taniguchi M., Watanabe K., Tang Y.;
RT   "Biosynthesis of the Immunosuppressant (-)-FR901483.";
RL   J. Am. Chem. Soc. 143:132-136(2021).
```

Source SHA-256: `f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)  
**Locator:** `lines 63-68`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 6 / 1.  
**Retrieved:** 2026-11-02T04:25:48.823356+00:00.  

```text
CC   -!- PATHWAY: Secondary metabolite biosynthesis.
CC       {ECO:0000269|PubMed:33372776}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
```

Source SHA-256: `f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 138. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
